These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 4645050)

  • 1. [Acquired factor IX-inhibitor in a non-hemophilic patient with autoimmune disease].
    Largo R; Sigg P; von Felten A; Straub PW
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1612-3. PubMed ID: 4645050
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation inhibitors.
    Corrigan JJ
    Am J Pediatr Hematol Oncol; 1980; 2(3):281-8. PubMed ID: 6776839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease.
    Largo R; Sigg P; von Felten A; Straub PW
    Br J Haematol; 1974 Jan; 26(1):129-40. PubMed ID: 4211775
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH
    Thromb Haemost; 1981 Dec; 46(4):684-6. PubMed ID: 7330818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired factor IX inhibitor in a patient with Christmas disease: case report.
    Riyat MS; Kasili EG; Omondi BE
    East Afr Med J; 1984 Feb; 61(2):159-62. PubMed ID: 6468323
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone.
    Mazzucconi MG; Peraino M; Bizzoni L; Bernasconi S; Luciani M; Rossi GD
    Haemophilia; 1999 Mar; 5(2):132-4. PubMed ID: 10215963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The different action of bovine and human factor VIII (anti-haemophilic globulin) on factor X consumption during coagulation].
    Mayer G; Mayer S; Waitz R
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):1028-31. PubMed ID: 5377890
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor IX of the blood coagulation system: a review.
    Taran LD
    Biochemistry (Mosc); 1997 Jul; 62(7):685-93. PubMed ID: 9331959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of venom of the central Asian cobra (Naja oxiana eich.) on the blood-coagulating system].
    Mitel'man LSh
    Biull Eksp Biol Med; 1966 Sep; 62(9):69-71. PubMed ID: 6012423
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IX-inhibitors. Report of two cases and a study of the biological, chemical and immunological properties of the inhibitors.
    Lechner K
    Thromb Diath Haemorrh; 1971 Jun; 25(3):447-59. PubMed ID: 5561957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autoimmune coagulopathy of an anti-factor IX (PTC) antibody. Description of a case and review of the literature. Its treatment with immunodepressor agents].
    Marmont A; Bertorello CF; Damasio E; Rossi F
    Folia Allergol (Roma); 1969; 16(1):13-48. PubMed ID: 5772154
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tissue factor expression at the site of inflammation: a cross-talk between inflammation and the blood coagulation system].
    Imamura T
    Rinsho Byori; 2004 Apr; 52(4):342-9. PubMed ID: 15164603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays.
    Prowse CV; Chirnside A; Elton RA
    Thromb Haemost; 1980 Feb; 42(5):1355-67. PubMed ID: 6768149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivo.
    Refino CJ; Himber J; Burcklen L; Moran P; Peek M; Suggett S; Devaux B; Kirchhofer D
    Thromb Haemost; 1999 Sep; 82(3):1188-95. PubMed ID: 10494786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent anti-coagulant RNA aptamer inhibits blood coagulation by specifically blocking the extrinsic clotting pathway.
    Gopinath SC; Shikamoto Y; Mizuno H; Kumar PK
    Thromb Haemost; 2006 May; 95(5):767-71. PubMed ID: 16676065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired factor V inhibitor after haematopoietic stem cell transplantation.
    Milojkovic D; Patel R; Ford E; Arya R; Mufti G
    Thromb Haemost; 2007 Sep; 98(3):685-7. PubMed ID: 17849062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.